サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412720

術中神経モニタリング市場：タイプ、モダリティ、アプリケーション別-2024-2030年の世界予測

Intraoperative Neuromonitoring Market by Type (Insource IONM, Outsource IONM), Modality (Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography), Application - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
術中神経モニタリング市場：タイプ、モダリティ、アプリケーション別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

術中神経モニタリング市場規模は2023年に31億3,000万米ドルと推計され、2024年には33億1,000万米ドルに達し、CAGR 5.69%で2030年には46億2,000万米ドルに達すると予測されます。

術中神経モニタリングの世界市場

主な市場の統計
基準年[2023］ 31億3,000万米ドル
予測年[2024］ 33億1,000万米ドル
予測年 [2030] 46億2,000万米ドル
CAGR（%） 5.69%
術中神経モニタリング Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは術中神経モニタリング市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、術中神経モニタリング市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-術中神経モニタリング市場の市場規模および予測は？

2-術中神経モニタリング市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-術中神経モニタリング市場における技術動向と規制の枠組みは？

4-術中神経モニタリング市場における主要ベンダーの市場シェアは？

5-術中神経モニタリング市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • さまざまなライフスタイルに関連する慢性疾患の罹患率の増加
      • 有利な償還政策とより安全な手術実施への要求
      • アウトソーシングの増加傾向術中神経モニタリング
    • 抑制要因
      • 高額な治療費
    • 機会
      • 手術中のリスクを最小限に抑えるための神経モニタリングの技術進歩
      • 政府機関による研究開発投資の増加
    • 課題
      • 熟練した専門家の不足と意識の低さ
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 術中神経モニタリング市場：タイプ別

  • インソース IONM
  • IONMのアウトソーシング

第7章 術中神経モニタリング市場：モダリティ別

  • 脳幹聴覚誘発電位
  • 脳波検査
  • 筋電図検査
  • モーター誘発電位
  • 体性感覚誘発電位
  • 視覚誘発潜在力

第8章 術中神経モニタリング市場：用途別

  • 耳鼻咽喉科手術
  • 脳神経外科
  • 整形外科
  • 脊椎外科
  • 血管手術

第9章 南北アメリカの術中神経モニタリング市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の術中神経モニタリング市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの術中神経モニタリング市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Accurate Monitoring, LLC
    • Argos Neuromonitoring LP
    • Biotronic NeuroNetwork, LLC
    • Cadwell Industries, Inc.
    • Computational Diagnostics, Inc.
    • Emotiv Inc.
    • inomed Medizintechnik GmbH
    • Intranerve, LLC
    • Medsurant Health
    • Medtronic PLC
    • Moberg Research Inc.
    • Natus Medical Incorporated
    • NeuroMonitoring Technologies
    • NeuroSentinel LLC
    • Nihon Kohden Corporation
    • NuVasive Inc
    • Procirca
    • ProPep Surgical
    • SpecialtyCare, Inc.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. INTRAOPERATIVE NEUROMONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRAOPERATIVE NEUROMONITORING MARKET DYNAMICS
  • FIGURE 7. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 10. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY INSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY OUTSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 9. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY BRAINSTEM AUDITORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROMYOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MOTOR EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SOMATOSENSORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VISUAL EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ENT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 149. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. INTRAOPERATIVE NEUROMONITORING MARKET LICENSE & PRICING
目次
Product Code: MRR-AD36CD8980CF

[181 Pages Report] The Intraoperative Neuromonitoring Market size was estimated at USD 3.13 billion in 2023 and expected to reach USD 3.31 billion in 2024, at a CAGR 5.69% to reach USD 4.62 billion by 2030.

Global Intraoperative Neuromonitoring Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.31 billion
Forecast Year [2030] USD 4.62 billion
CAGR (%) 5.69%
Intraoperative Neuromonitoring Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intraoperative Neuromonitoring Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intraoperative Neuromonitoring Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intraoperative Neuromonitoring Market, highlighting leading vendors and their innovative profiles. These include Accurate Monitoring, LLC, Argos Neuromonitoring LP, Biotronic NeuroNetwork, LLC, Cadwell Industries, Inc., Computational Diagnostics, Inc., Emotiv Inc., inomed Medizintechnik GmbH, Intranerve, LLC, Medsurant Health, Medtronic PLC, Moberg Research Inc., Natus Medical Incorporated, NeuroMonitoring Technologies, NeuroSentinel LLC, Nihon Kohden Corporation, NuVasive Inc, Procirca, ProPep Surgical, and SpecialtyCare, Inc..

Market Segmentation & Coverage

This research report categorizes the Intraoperative Neuromonitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Insource IONM
    • Outsource IONM
  • Modality
    • Brainstem Auditory Evoked Potentials
    • Electroencephalography
    • Electromyography
    • Motor Evoked Potentials
    • Somatosensory Evoked Potentials
    • Visual Evoked Potentials
  • Application
    • ENT Surgery
    • Neurosurgery
    • Orthopedic Surgery
    • Spinal Surgery
    • Vascular Surgery
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intraoperative Neuromonitoring Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intraoperative Neuromonitoring Market?

3. What are the technology trends and regulatory frameworks in the Intraoperative Neuromonitoring Market?

4. What is the market share of the leading vendors in the Intraoperative Neuromonitoring Market?

5. Which modes and strategic moves are suitable for entering the Intraoperative Neuromonitoring Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Intraoperative Neuromonitoring Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of various lifestyles associated chronic diseases
      • 5.1.1.2. Favorable reimbursement policies and demand for safer surgery practices
      • 5.1.1.3. Rising trend of outsourcing Intraoperative Neuromonitoring
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in neuromonitoring to minimize the risks during surgery
      • 5.1.3.2. Increased R&D investments by governmental bodies
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and low awareness
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Intraoperative Neuromonitoring Market, by Type

  • 6.1. Introduction
  • 6.2. Insource IONM
  • 6.3. Outsource IONM

7. Intraoperative Neuromonitoring Market, by Modality

  • 7.1. Introduction
  • 7.2. Brainstem Auditory Evoked Potentials
  • 7.3. Electroencephalography
  • 7.4. Electromyography
  • 7.5. Motor Evoked Potentials
  • 7.6. Somatosensory Evoked Potentials
  • 7.7. Visual Evoked Potentials

8. Intraoperative Neuromonitoring Market, by Application

  • 8.1. Introduction
  • 8.2. ENT Surgery
  • 8.3. Neurosurgery
  • 8.4. Orthopedic Surgery
  • 8.5. Spinal Surgery
  • 8.6. Vascular Surgery

9. Americas Intraoperative Neuromonitoring Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intraoperative Neuromonitoring Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intraoperative Neuromonitoring Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Accurate Monitoring, LLC
    • 13.1.2. Argos Neuromonitoring LP
    • 13.1.3. Biotronic NeuroNetwork, LLC
    • 13.1.4. Cadwell Industries, Inc.
    • 13.1.5. Computational Diagnostics, Inc.
    • 13.1.6. Emotiv Inc.
    • 13.1.7. inomed Medizintechnik GmbH
    • 13.1.8. Intranerve, LLC
    • 13.1.9. Medsurant Health
    • 13.1.10. Medtronic PLC
    • 13.1.11. Moberg Research Inc.
    • 13.1.12. Natus Medical Incorporated
    • 13.1.13. NeuroMonitoring Technologies
    • 13.1.14. NeuroSentinel LLC
    • 13.1.15. Nihon Kohden Corporation
    • 13.1.16. NuVasive Inc
    • 13.1.17. Procirca
    • 13.1.18. ProPep Surgical
    • 13.1.19. SpecialtyCare, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing